Cite
Ringheim GE, Lee L, Laws-Ricker L, et al. Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis. Front Neurol. 2013;4:169doi: 10.3389/fneur.2013.00169.
Ringheim, G. E., Lee, L., Laws-Ricker, L., Delohery, T., Liu, L., Zhang, D., Colletti, N., Soos, T. J., Schroeder, K., Fanelli, B., Tian, N., Arendt, C. W., Iglesias-Bregna, D., Petty, M., Ji, Z., Qian, G., Gaur, R., Weinstock, D., Cavallo, J., Telsinskas, J., & McMonagle-Strucko, K. (2013). Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis. Frontiers in neurology, 4169. https://doi.org/10.3389/fneur.2013.00169
Ringheim, Garth E, et al. "Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis." Frontiers in neurology vol. 4 (2013): 169. doi: https://doi.org/10.3389/fneur.2013.00169
Ringheim GE, Lee L, Laws-Ricker L, Delohery T, Liu L, Zhang D, Colletti N, Soos TJ, Schroeder K, Fanelli B, Tian N, Arendt CW, Iglesias-Bregna D, Petty M, Ji Z, Qian G, Gaur R, Weinstock D, Cavallo J, Telsinskas J, McMonagle-Strucko K. Teriflunomide attenuates immunopathological changes in the dark agouti rat model of experimental autoimmune encephalomyelitis. Front Neurol. 2013 Oct 30;4:169. doi: 10.3389/fneur.2013.00169. eCollection 2013. PMID: 24198809; PMCID: PMC3812666.
Copy
Download .nbib